Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Tilly Jonathan L — Tempest Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Tilly Jonathan L

Tilly Jonathan L

Director at Tempest Therapeutics, Inc. · on record since Jun 11, 2012

Insider trading activity of Tilly Jonathan L

Transactions on record: 1; since Jun 11, 2013

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jun 11, 2013

Figures computed from official regulatory filings — methodology.

Companies where Tilly Jonathan L has traded

Tempest Therapeutics, Inc.1 tx · Jun 11, 2013

Track record of Tilly Jonathan L

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Tilly Jonathan L

Co-insiders of Tilly Jonathan L

ALDRICH RICHARDTempest Therapeutics, Inc.
Angel MatthewTempest Therapeutics, Inc.
Arbet-Engels ChristopheTempest Therapeutics, Inc.
Arcudi Louis J.Tempest Therapeutics, Inc.
BARRIS PETER JTempest Therapeutics, Inc.
BASKETT FORESTTempest Therapeutics, Inc.
Bessemer Venture Partners VII Institutional L.P.Tempest Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Bessemer Venture Partners VII L.P.Tempest Therapeutics, Inc.

BLECK CHRISTOPHER ATempest Therapeutics, Inc.

Brady Stephen RTempest Therapeutics, Inc.

Brinza Jeffery M.Tempest Therapeutics, Inc.

BVP VII SPECIAL OPPORTUNITY FUND LPTempest Therapeutics, Inc.

CAPELLO JEFFREY DTempest Therapeutics, Inc.

CHAPMAN PAUL W.D.Tempest Therapeutics, Inc.

Chappel Scott CTempest Therapeutics, Inc.

Couturier ChristopheTempest Therapeutics, Inc.

Cutler Joel ETempest Therapeutics, Inc.

Dable Habib JTempest Therapeutics, Inc.

Deer Management Co. LLCTempest Therapeutics, Inc.

Deer VII & Co. L.P.Tempest Therapeutics, Inc.

Deer VII & Co. Ltd.Tempest Therapeutics, Inc.

Dipp MichelleTempest Therapeutics, Inc.

Dubensky Thomas W.Tempest Therapeutics, Inc.

FHM VI, L.L.C.Tempest Therapeutics, Inc.

FHM VI, L.P.Tempest Therapeutics, Inc.

Fialkow David PTempest Therapeutics, Inc.

FISHER MARYTempest Therapeutics, Inc.

Florence Anthony A. Jr.Tempest Therapeutics, Inc.

Frazier Healthcare VI, L.P.Tempest Therapeutics, Inc.

Gallagher Carol GiltnerTempest Therapeutics, Inc.

GC Entrepreneurs Fund V, LPTempest Therapeutics, Inc.

General Catalyst GP V, LLCTempest Therapeutics, Inc.

General Catalyst Group V LPTempest Therapeutics, Inc.

General Catalyst Partners V, L.P.Tempest Therapeutics, Inc.

GILLIS JONATHANTempest Therapeutics, Inc.

Harding DavidTempest Therapeutics, Inc.

Hedley Mary LynneTempest Therapeutics, Inc.

Hindman James M.Tempest Therapeutics, Inc.

HOWE JOHN P MDTempest Therapeutics, Inc.

JOSEPH TAMARA LTempest Therapeutics, Inc.

KOZIN MARC DTempest Therapeutics, Inc.

Kraus StephenTempest Therapeutics, Inc.

Kroeger Christopher A.Tempest Therapeutics, Inc.

LAWTON ALISON FRANCISTempest Therapeutics, Inc.

Lillie James WoodruffTempest Therapeutics, Inc.

Lindblom Christopher MTempest Therapeutics, Inc.

Longwood Fund, L.P.Tempest Therapeutics, Inc.

Lorenzo PierreTempest Therapeutics, Inc.

Maestas NicholasTempest Therapeutics, Inc.

Makhzoumi MohamadTempest Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Tempest Therapeutics, Inc.	Jun 11, 2013	AwardD	4,448	0.00 USD	$0	SEC